The timing of this presentation should coincide with data from the Shionogi drug. They announced completion of enrollment in December but said the trial would be kept blinded for 3 months to get 12 week data on symptoms for a look on drug effect on long covid (they are planning to follow patients for 6 months total).
News 
Market Data 
Discover 
